Web-based and iPad tablet application solution for writing investigator-initiated research protocols
(Lake Success, NY) - BRANY has announced the launch of Protocol Builder™, a first-of-its-kind solution to assist researchers in the development of investigator-initiated research protocols. This web-based application, accessible from any desktop and iPad tablet, is designed to provide expert guidance and a step-by-step process to make protocol development faster and less onerous. Resources necessary to navigate the elaborate regulatory infrastructure that surrounds clinical research in the U.S. are at researchers’ fingertips in this thoughtfully designed application.
“Many investigators find the regulatory and compliance hurdles difficult and time-consuming to navigate when writing protocols,” says Kimberly Irvine, Executive Vice President and Chief Operating Officer at BRANY. “Protocol Builder ensures efficiency and accuracy in developing a complete protocol, ready to submit to the IRB. By following the guided steps in Protocol Builder, investigators will save time and be better able to provide an omission-free protocol for review. Our objective with Protocol Builder is to use technology to empower researchers to achieve their research goals with less effort.”
Utilizing a team of leading experts in both consumer design and investigator-initiated clinical research, BRANY developed a step-by-step intuitive approach to building a protocol. BRANY has deconstructed the complex process of writing research protocols and designed a tool that’s innovative, packed with time-saving features, yet easy to use.
While many institutions provide templates and training to investigators writing investigator-initiated protocols, research shows a high degree of dissatisfaction with these tools. Protocol Builder reduces the complexities in investigator-initiated protocol development and is an excellent tool for both experienced and new investigators.
Protocol Builder is available to institutions through corporate licenses, and to individual investigators through single user licenses. For more information or to sign up for a free demo, please visit www.protocolbuilderpro.com, or contact (516) 499-5645.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.